J Immunol. 2000 Nov 15;165(10):5962-9.
Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B,activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
Cancer Res. 2000 Jul 15;60(14):3838-47.
Oleandrin suppresses activation of nuclear transcription factor-kappaB, activatorprotein-1, and c-Jun NH2-terminal kinase.
J Immunol. 2000 Jun 15;164(12):6509-19.
Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygenintermediates and lipid peroxidation.
J Immunol. 2000 Jun 1;164(11):5815-25.
Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, andapoptosis.
J Immunol. 1999 Dec 15;163(12):6800-9.
Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
See two comments on Retraction Watch (MD Anderson investigating researcher Bharat Aggarwal over images) .
If you look back at his publications around 2000, 2001, 2002, there are plenty of issues
Somehow they made water soluble resveratrol!
The same control values appear for lipid peroxidation in a few publications too
http://cancerres.aacrjournals.org/content/60/14/3838.long
http://www.jimmunol.org/content/165/10/5962.long
http://www.jimmunol.org/content/165/10/5962.long
“Untreated cells showed 0.571 ± 0.126 nmol of MDA equivalents/mg of protein” appears in all these papers (unless I’m seeing double, I mean double double). So all the controls have been published multiple times???
0 件のコメント:
コメントを投稿